相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry
Pratibha Yadav et al.
BIOORGANIC CHEMISTRY (2021)
A comprehensive review on the biological interest of quinoline and its derivatives
Basavarajaiah Suliphuldevara Matada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia
Luiz Claudio Ferreira Pimentel et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2021)
Phenylamino-pyrimidine (PAP) Privileged Structure: Synthesis and Medicinal Applications
Luiz Claudio Ferreira Pimentel et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity
Samar H. Abbas et al.
BIOORGANIC CHEMISTRY (2019)
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
Sonia Martinez-Gonzalez et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking
Jeffrey R. Wagner et al.
STRUCTURE (2019)
Quinoline and ferrocene conjugates: Synthesis, computational study and biological evaluations
Silvija Maracic et al.
APPLIED ORGANOMETALLIC CHEMISTRY (2019)
Biological evaluation of some quinoline derivatives with different functional groups as anticancer agents
Tugba Kul Koprulu et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2019)
Therapeutic potential of heterocyclic pyrimidine scaffolds
Sanjiv Kumar et al.
CHEMISTRY CENTRAL JOURNAL (2018)
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy
Federico Rossari et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Synthesis, Structure, Chemical Stability, and In Vitro Cytotoxic Properties of Novel Quinoline-3-Carbaldehyde Hydrazones Bearing a 1,2,4-Triazole or Benzotriazole Moiety
Martyna Korcz et al.
MOLECULES (2018)
A comprehensive review of protein kinase inhibitors for cancer therapy
Radhamani Kannaiyan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
Chen Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Imatinib derivatives as inhibitors of K562 cells in chronic myeloid leukemia
Liviane D. Azevedo et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Novel members of quinoline compound family enhance insulin secretion in RIN-5AH beta cells and in rat pancreatic islet microtissue
Z. Orfi et al.
SCIENTIFIC REPORTS (2017)
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Hochhaus et al.
ANNALS OF ONCOLOGY (2017)
Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib
Yong-Tao Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
William V. Padula et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Lead Discovery of Type II BRAF V600E Inhibitors Targeting the Structurally Validated DFG-Out Conformation Based upon Selected Fragments
Qingwen Zhang et al.
MOLECULES (2016)
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States
William V. Padula et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Anti-breast cancer activity of some novel quinoline derivatives
Mostafa M. Ghorab et al.
ACTA PHARMACEUTICA (2015)
Fluorinated Compounds Against Mycobacterium tuberculosis
Nubia Boechat et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Synthesis and biological evaluation of thieno [2′,3′:4,5]pyrimido[1,2-b][1,2,4]triazines and thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidines as anti-inflammatory and analgesic agents
Hayam M. Ashour et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure and Dynamic Regulation of Abl Kinases
Shoghag Panjarian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML
Gianantonio Rosti et al.
CANCER TREATMENT REVIEWS (2012)
The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
Rupashree Sen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Preparation of H,4 PyrrolidineQuin-BAM (PBAM)
Tyler A. Davis et al.
ORGANIC SYNTHESES (2012)
Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
Nicholas M. Levinson et al.
PLOS ONE (2012)
Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site
Jingsong Yang et al.
CHEMISTRY & BIOLOGY (2011)
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the Synthesis of Inhibitors of Bcr-Abl
Federica Arioli et al.
CHEMMEDCHEM (2011)
Patients' age and BCR-ABL frequency in adult B-precursor ALL:: a retrospective analysis from the GMALL study group
Thomas Burmeister et al.
BLOOD (2008)
Microwave enhancement of a 'one-pot' tandem azidation-'click' cycloaddition of anilines
Adam D. Moorhouse et al.
SYNLETT (2008)
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives
MT Cocco et al.
FARMACO (2001)
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
J O'Brien et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
